Should medical cannabis use disqualify someone from receiving a kidney transplant?

A 20-year-old woman was initially denied a renal transplant listing due to her medical cannabis use, raising ethical questions about using legal medical treatments as barriers to life-saving procedures.

Ryan, Jennie E et al.·Pediatric transplantation·2019·Preliminary EvidenceCase Report
RTHC-02269Case ReportPreliminary Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

A 20-year-old woman recommended for renal transplant was originally denied active listing because of her medical cannabis use. The review found that many healthcare providers are uninformed or misinformed about the actual risks of cannabis in immunocompromised patients.

Key Numbers

Medical cannabis is legal in over half of US states. 1 patient initially denied transplant listing. Few professional organizations provide guidance on this issue.

How They Did This

Ethical case study with literature review examining perceived versus actual risks of cannabis use in transplant patients and the ethics of denying transplants based on medical cannabis use.

Why This Research Matters

As medical cannabis becomes legal in more states, transplant teams will increasingly face this dilemma. Denying life-saving treatment based on a legal medical therapy raises serious ethical concerns.

The Bigger Picture

Organ allocation decisions have enormous consequences. If medical cannabis use becomes a de facto disqualifier, patients in legal states may be punished for following their physicians' recommendations.

What This Study Doesn't Tell Us

Single case report. The actual transplant outcomes for cannabis users versus non-users remain poorly studied. The ethics discussion, while important, is opinion-based.

Questions This Raises

  • ?Does medical cannabis actually worsen transplant outcomes?
  • ?Should transplant teams differentiate between medical and recreational cannabis use?
  • ?Could standardized guidelines prevent inconsistent decisions?

Trust & Context

Key Stat:
Patient denied transplant listing for using legal medical cannabis
Evidence Grade:
Preliminary: single case report with ethical analysis.
Study Age:
Published in 2019.
Original Title:
Denying renal transplantation to an adolescent medical cannabis user: An ethical case study.
Published In:
Pediatric transplantation, 23(5), e13467 (2019)
Database ID:
RTHC-02269

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

Do transplant centers routinely deny cannabis users?

Practices vary widely. Many transplant programs still consider any cannabis use a relative or absolute contraindication, even in states where it is legally prescribed.

Does cannabis actually harm transplant outcomes?

The evidence is limited. The review found that many perceived risks are not well-supported by data, and healthcare providers often rely on outdated or inaccurate assumptions about cannabis risks in immunocompromised patients.

Read More on RethinkTHC

Cite This Study

RTHC-02269·https://rethinkthc.com/research/RTHC-02269

APA

Ryan, Jennie E; Noeder, Maia; Burke, Christine; Stubblefield, Samuel C; Sulieman, Salwa; Miller, Elissa G. (2019). Denying renal transplantation to an adolescent medical cannabis user: An ethical case study.. Pediatric transplantation, 23(5), e13467. https://doi.org/10.1111/petr.13467

MLA

Ryan, Jennie E, et al. "Denying renal transplantation to an adolescent medical cannabis user: An ethical case study.." Pediatric transplantation, 2019. https://doi.org/10.1111/petr.13467

RethinkTHC

RethinkTHC Research Database. "Denying renal transplantation to an adolescent medical canna..." RTHC-02269. Retrieved from https://rethinkthc.com/research/ryan-2019-denying-renal-transplantation-to

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.